Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based bioph... Read more
Alnylam Pharmaceuticals
51 followers
PCI Pharma Services
14 followers
Amplity Health
4 followers
ProPharma Group
3 followers
UBC
3 followers
BMWC Constructors
3 followers
Incyte
37 followers
Riverside Unified School District
2 followers
Novavax
13 followers
Agiliti
9 followers
EVERSANA
8 followers
Phillips-Medisize
1 follower